Executive Summary |
|
1 | (2) |
|
The Charge to the Committee |
|
|
2 | (1) |
|
The Committee's Approach to Its Charge |
|
|
2 | (1) |
|
The Committee's Evaluation |
|
|
3 | (7) |
|
|
10 | (2) |
|
|
12 | (8) |
|
|
13 | (1) |
|
Conclusions of Previous Veterans and Agent Orange Reports |
|
|
13 | (5) |
|
Organization of this Report |
|
|
18 | (1) |
|
|
19 | (1) |
|
Considerations in Evaluating the Evidence |
|
|
20 | (10) |
|
Choice of Health Outcomes |
|
|
20 | (1) |
|
Identification of Relevant Literature |
|
|
20 | (2) |
|
Committee's Approach to Its Charge |
|
|
22 | (2) |
|
Issues in Evaluating the Evidence |
|
|
24 | (4) |
|
|
28 | (2) |
|
|
30 | (73) |
|
Highlights of Previous Reports |
|
|
31 | (1) |
|
Toxicity Profile Update of 2,4-D |
|
|
31 | (6) |
|
Toxicity Profile Update of 2,4,5-T |
|
|
37 | (1) |
|
Toxicity Profile Update of Cacodylic Acid |
|
|
38 | (2) |
|
Toxicity Profile Update of Picloram |
|
|
40 | (1) |
|
Toxicity Profile Update of TCDD |
|
|
40 | (36) |
|
Summary of Toxicity Profiles |
|
|
76 | (5) |
|
Relevance to Human Health |
|
|
81 | (1) |
|
|
82 | (21) |
|
Overview of Epidemiologic Studies |
|
|
103 | (112) |
|
|
104 | (11) |
|
|
115 | (3) |
|
|
118 | (76) |
|
|
194 | (21) |
|
|
215 | (27) |
|
Exposure Assessment for Epidemiology |
|
|
215 | (2) |
|
Occupational Exposure to Herbicides and TCDD |
|
|
217 | (9) |
|
Environmental Exposure to Herbicides and TCDD |
|
|
226 | (3) |
|
Military Use of Herbicides in Vietnam |
|
|
229 | (3) |
|
Exposure Assessment in Studies of Vietnam Veterans |
|
|
232 | (3) |
|
|
235 | (7) |
|
|
242 | (151) |
|
Gastrointestinal Tract Tumors |
|
|
243 | (16) |
|
|
259 | (5) |
|
|
264 | (4) |
|
|
268 | (4) |
|
|
272 | (6) |
|
|
278 | (4) |
|
|
282 | (5) |
|
|
287 | (8) |
|
Skin Cancer---Basal-cell and Squamous-cell (Nonmelanoma) |
|
|
295 | (5) |
|
|
300 | (9) |
|
Cancers of the Female Reproductive System |
|
|
309 | (7) |
|
|
316 | (8) |
|
|
324 | (4) |
|
|
328 | (5) |
|
|
333 | (5) |
|
|
338 | (5) |
|
|
343 | (12) |
|
|
355 | (6) |
|
|
361 | (5) |
|
|
366 | (6) |
|
Chronic Lymphocytic Leukemia |
|
|
372 | (4) |
|
|
376 | (5) |
|
|
381 | (12) |
|
Reproductive and Developmental Effects |
|
|
393 | (54) |
|
|
393 | (12) |
|
|
405 | (4) |
|
|
409 | (12) |
|
Stillbirth, Neonatal Death, and Infant Death |
|
|
421 | (1) |
|
Low Birthweight and Preterm Delivery |
|
|
422 | (3) |
|
|
425 | (7) |
|
|
432 | (6) |
|
|
438 | (3) |
|
|
441 | (6) |
|
Neurobehavioral Disorders |
|
|
447 | (30) |
|
Cognitive and Neuropsychiatric Effects |
|
|
448 | (4) |
|
Motor or Coordination Dysfunction |
|
|
452 | (13) |
|
Chronic Persistent Peripheral Neuropathy |
|
|
465 | (4) |
|
Acute and Subacute Transient Peripheral Neuropathy |
|
|
469 | (1) |
|
|
470 | (2) |
|
|
472 | (5) |
|
|
477 | (46) |
|
|
477 | (2) |
|
|
479 | (1) |
|
|
480 | (3) |
|
|
483 | (2) |
|
|
485 | (8) |
|
Lipid and Lipoprotein Disorders |
|
|
493 | (5) |
|
Gastrointestinal and Digestive Disease, Including Liver Toxicity |
|
|
498 | (4) |
|
|
502 | (4) |
|
|
506 | (2) |
|
|
508 | (2) |
|
|
510 | (4) |
|
|
514 | (5) |
|
|
519 | (4) |
|
|
523 | (16) |
|
|
523 | (3) |
|
Studies of the Vietnamese |
|
|
526 | (1) |
|
|
526 | (1) |
|
|
527 | (2) |
|
|
|
A Agendas of Public Meetings |
|
|
529 | (2) |
|
B ICD-9 Codes for Health Outcomes of Interest |
|
|
531 | (3) |
|
C Committee and Staff Biographies |
|
|
534 | (5) |
Index |
|
539 | |